It is unusual for a discipline if that is the right word, to survive and thrive for over 30 years where the principal product is a framework for creating imaginary value claims for pharmaceutical products. Yet this is the situation that health technology has been promoted, and continues to promote, through professional associations such as the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) with organizations such as the Institute for Clinical and Economic Review. (ICER) and the National Pharmaceutical Council (NPC).

Read more